IN THE NEWS: Karmanos Cancer Institute joins trial for potential Coronavirus-fighting drug

From WDET, 101.9 FM

Jeffrey Zonder, M.D., leader of the Multiple Myeloma Multidisciplinary Team at Karmanos Cancer Institute, talks with Russ McNamara about an upcoming Clinical Trial for a COVID-19 treatment at Karmanos.

Researchers at Karmanos participated in the development of this drug, which has been FDA approved for the treatment of multiple myeloma. Now, Karmanos is participating in clinical trials testing this drug for the treatment of COVID-19.

Click here to listen to the complete story on WDET.

Download Audio

See the full story on